Kardigan, Inc.
Public company- Headquarters
- SOUTH SAN FRANCISCO, California
- Ticker
- KARD
- CIK
- 0002123613
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| board of directorsDoug Giordano | Sep 30, 2026 | Departed |
| Class I directorKristin Reinke | Sep 30, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive departure
board of directors departs: Doug Giordano
Doug Giordano, board of directors of Kardigan, Inc., resigns the role, effective September 29, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: board of directors
- Executive appointment
Class I director appointed: Kristin Reinke
Kristin Reinke was named Class I director of Kardigan, Inc., effective September 29, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: Class I director
Last verified Nov 9, 2026